focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

IN BRIEF: Crossword Cybersecurity bolsters board with two appointments

Tue, 25th May 2021 21:26

Crossword Cybersecurity PLC - Richmond, England-based cyber security and risk-focused technology commercialisation company - Announces the appointment of Tara Cemlyn-Jones and Robert Coles to the board of the company as non-executive directors with immediate effect.

"Tara Cemlyn-Jones has 28 years' experience in financial services with specialist knowledge of capital markets, mergers & acquisitions, strategy and digital transformation across many sectors, including financial services (asset & wealth management, retail banking and fintech), energy & infrastructure and healthcare," says Crossword.

"Robert Coles is a highly experienced IT Risk and Cyber Security leader. He is the former chief information security officer of GlaxoSmithKline PLC and of the NHS, with over 30 years commercial experience. Prior to his time at the NHS, Robert Coles worked for GlaxoSmithKline from 2013 and was the company's chief information security officer," adds company.

Current stock price: 417.40 pence

Year-to-date change: up 52%

By Greg Roxburgh; gregroxburgh@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

Related Shares

More News
Today 11:23

AstraZeneca aims for $80 bln in total revenue by 2030

Sees $80 bln in 2030 revenue by 2030 *

Today 08:49

GSK's depemokimab asthma treatment meets endpoints in latest trials

(Alliance News) - GSK PLC on Tuesday announced positive results from trials of depemokimab, an "ultra-long-acting biologic" that could simplify treatm...

Today 07:21

GSK reports promising results from asthma treatment trials

(Sharecast News) - GSK announced promising results from phase three clinical trials evaluating the efficacy and safety of depemokimab in treating seve...

20 May 2024 16:11

IN BRIEF: GSK executive buys GBP20,026 worth shares

GSK PLC - London-based pharmaceuticals firm - Senior Vice President, Global Communications & Chief Executive Office, Sally Jackson, buys 1,120 shares ...

17 May 2024 17:38

London's FTSE nudges lower for week after record run

Haleon falls after GSK offloads remaining stake *

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.